1. Lilly to test COVID-19 antibody drug in unorthodox nursing home study — Prepare for an influx of cell and gene therapy approvals — Regeneron pairs with BioNTech on melanoma immunotherapy — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Opinion on Olivier G?

Discussion in 'Takeda IT' started by l00ptruy, May 8, 2016 at 12:24 AM.

  1. l00ptruy

    l00ptruy new user

    Joined:
    May 7, 2016
    Messages:
    2
    Likes Received:
    0
    what do you guys, think? Doing a good job? will last long or not so long?
     

  2. anonymous

    anonymous Guest

    OG would have been a good CIO in the 1990s. i heard that's where a McK study ranked takeda for ISIT infrastructure...now we only have 30 years to catch up on. and his leadership teams meet face to face monthly costing the company at least $80k in travel. way to go OG